New 52 Week Low Today

OncoTherapy Science Inc 4564.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
63.00UNCH (UNCH)
Volume
635,400
52 week range
62.00 - 126.00
Loading...
  • Open63.00
  • Day High64.00
  • Day Low62.00
  • Prev Close63.00
  • 52 Week High126.00
  • 52 Week High Date06/18/21
  • 52 Week Low62.00
  • 52 Week Low Date05/19/22

Key Stats

  • Market Cap93.82M
  • Shares Out192.64M
  • 10 Day Average Volume759,980
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-12.5

KEY STATS

  • Open63.00
  • Day High64.00
  • Day Low62.00
  • Prev Close63.00
  • 52 Week High126.00
  • 52 Week High Date06/18/21
  • 52 Week Low62.00
  • 52 Week Low Date05/19/22
  • Market Cap93.82M
  • Shares Out192.64M
  • 10 Day Average Volume759,980
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-12.5

RATIOS/PROFITABILITY

  • EPS (TTM)-8.30
  • P/E (TTM)-7.59
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On OncoTherapy Science Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
OncoTherapy Science, Inc. is a Japan-based company mainly engaged in the development of drugs. The Company is involved in the development of low molecular drugs, antibody drugs and other drugs, as well as the provision and clinical development of medical candidate substances. The Company operates its business in cooperation with universities and other corporations. The Company provides its licenses to pharmaceutical manufacturers. The Company also involves in T Cell...
Hatsuo Kato
Chairman of the Board
Jae Park
President, Chief Executive Officer, Chief Scientific Officer, President of Subsidiary, Representative Director
Address
6F, Kanagawa Science Park R&D Bldg. D
3-2-1, Sakado, Takatsu-ku
Kawasaki-shi, KNG
213-0012
Japan